7 July 2026

Diabetes Obesity Pharmaceuticals

Triple hormone receptor agonist improves glycaemic control and bodyweight reduction in T2D

5 June 2026

Diabetes Obesity Research

A potential new way to target excess glycogen stores

28 October 2025

Diabetes Pharmaceuticals TGA

Oral GLP-1 set for TGA submission

1 August 2025

Diabetes Public Health

Artificial sweeteners tied to 38% higher diabetes risk

13 May 2025

Diabetes Obesity Pharmaceuticals

Obesity drug leads to 25% weight loss in a third of patients

15 April 2025

Cardiology Diabetes Pharmaceuticals

What Ozempic is and isn’t good for

17 December 2024

Diabetes Obesity

Even more things GLP-1 RAs can do

19 November 2024

Diabetes Obesity Pharmaceuticals

Tirzepatide safe, highly effective for three years

24 September 2024

Diabetes

Quick bites from the EASD diabetes conference

27 August 2024

Diabetes Obesity

‘Exciting’ discovery on metabolic disease triggers

2 July 2024

Diabetes

Biomarkers for type 2 diabetes identified in the gut microbiota

4 June 2024

Diabetes Gastroenterology Obesity Pharmaceuticals

‘Significant issue’: surgical risks of GLP-1 RAs